Informatie:
Fout:
ID
22038
Beschrijving
Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00379262
Link
https://clinicaltrials.gov/show/NCT00379262
Trefwoorden
Versies (1)
- 16-05-17 16-05-17 -
Geüploaded op
16 mei 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Nasopharyngeal Carcinoma NCT00379262
Eligibility Nasopharyngeal Carcinoma NCT00379262
- StudyEvent: Eligibility
Similar models
Eligibility Nasopharyngeal Carcinoma NCT00379262
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Nasopharyngeal carcinoma | First line treatment Intent Radical
Item
histologically proven nasopharyngeal carcinoma for primary treatment with radical intent
boolean
C2931822 (UMLS CUI [1])
C1708063 (UMLS CUI [2,1])
C1283828 (UMLS CUI [2,2])
C0439807 (UMLS CUI [2,3])
C1708063 (UMLS CUI [2,1])
C1283828 (UMLS CUI [2,2])
C0439807 (UMLS CUI [2,3])
Nasopharyngeal Nonkeratinizing Carcinoma | Undifferentiated carcinoma of nasopharynx
Item
non-keratinizing or undifferentiated type
boolean
C1334926 (UMLS CUI [1])
C0279748 (UMLS CUI [2])
C0279748 (UMLS CUI [2])
Disease TNM clinical staging
Item
stage iii-ivb (by ajcc/uicc 6th edition)
boolean
C0012634 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,2])
ECOG performance status
Item
ecog performance status less or equal to 2
boolean
C1520224 (UMLS CUI [1])
Bone Marrow function | White Blood Cell Count procedure | Platelet Count measurement
Item
marrow: wbc >= 4 and platelet >=100
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0023508 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0031843 (UMLS CUI [1,2])
C0023508 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
Renal function | Creatinine clearance measurement
Item
renal: creatinine clearance >=60
boolean
C0232804 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
C0373595 (UMLS CUI [2])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
First line treatment Intent Palliative
Item
primary treatment with palliative intent
boolean
C1708063 (UMLS CUI [1,1])
C1283828 (UMLS CUI [1,2])
C1285530 (UMLS CUI [1,3])
C1283828 (UMLS CUI [1,2])
C1285530 (UMLS CUI [1,3])
Squamous cell carcinoma WHO tumor classification | Adenocarcinoma WHO tumor classification
Item
who type i squamous cell carcinoma or adenocarcinoma
boolean
C0007137 (UMLS CUI [1,1])
C1301142 (UMLS CUI [1,2])
C0001418 (UMLS CUI [2,1])
C1301142 (UMLS CUI [2,2])
C1301142 (UMLS CUI [1,2])
C0001418 (UMLS CUI [2,1])
C1301142 (UMLS CUI [2,2])
Distant metastasis Evidence of
Item
evidence of distant metastases
boolean
C1269798 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C0332120 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
patient is pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Malignant Neoplasm | Basal cell carcinoma Treated | Squamous cell carcinoma of skin Treated | Carcinoma in situ of uterine cervix | Malignant Neoplasm Disease Free of
Item
prior malignancy except adequately treated basal cell or squamous cell skin cancer, in-situ cervical cancer or other cancer for which the patient has been disease-free for 5 years
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C0553723 (UMLS CUI [3,1])
C1522326 (UMLS CUI [3,2])
C0851140 (UMLS CUI [4])
C0006826 (UMLS CUI [5,1])
C0012634 (UMLS CUI [5,2])
C0332296 (UMLS CUI [5,3])
C0007117 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C0553723 (UMLS CUI [3,1])
C1522326 (UMLS CUI [3,2])
C0851140 (UMLS CUI [4])
C0006826 (UMLS CUI [5,1])
C0012634 (UMLS CUI [5,2])
C0332296 (UMLS CUI [5,3])